ServicenavigationHauptnavigationTrailKarteikarten

Forschungsstelle
INNOSUISSE
Projektnummer
29722.1 IP-LS
Projekttitel
Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.
Projekttitel Englisch
Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.

Texte zu diesem Projekt
 DeutschFranzösischItalienischEnglisch
Kurzbeschreibung
Anzeigen
-
-
Anzeigen
Abstract
Anzeigen
-
-
-

Erfasste Texte


KategorieText
Kurzbeschreibung
(Deutsch)
Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.
Kurzbeschreibung
(Englisch)
Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.
Abstract
(Deutsch)
This project aims to validate and provide necessary data on the molecular target(-s) of our novel anti-Wnt signaling scaffold demonstrating excellent anti-cancer properties and safety profile. These data are essential for their acceptance and further structure-driven development in pharma companies.